A carregar...

Osteopontin Blockade Immunotherapy Increases Cytotoxic T Lymphocyte Lytic Activity and Suppresses Colon Tumor Progression

SIMPLE SUMMARY: Despite the breakthrough in human cancer immunotherapy, colorectal cancer, except for the small subset of microsatellite instable colorectal cancer (MSI, ~4% total cases), is one of the few human cancers that does not respond to current immune checkpoint inhibitor (ICI) immunotherapy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Klement, John D., Poschel, Dakota B., Lu, Chunwan, Merting, Alyssa D., Yang, Dafeng, Redd, Priscilla S., Liu, Kebin
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7957528/
https://ncbi.nlm.nih.gov/pubmed/33670921
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13051006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!